Active Biotech AB (OSTO:ACTI) Asset Impairment Charge : kr0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Asset Impairment Charge?

Active Biotech AB's Asset Impairment Charge for the three months ended in Mar. 2024 was kr0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

Active Biotech AB Asset Impairment Charge Historical Data

The historical data trend for Active Biotech AB's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Asset Impairment Charge Chart

Active Biotech AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Active Biotech AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Active Biotech AB Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Active Biotech AB Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Active Biotech AB (OSTO:ACTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

BTPC:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.activebiotech.com

Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines